225 related articles for article (PubMed ID: 32588837)
1. [Evaluation of incidence and risk profile for suffering Covid-19 infection by underlying conditions among middle-aged and older adults in Tarragona.].
Vila-Córcoles Á; Ochoa-Gondar O; Torrente-Fraga C; Vila-Rovira Á; Satué-Gracia E; Hospital-Guardiola I; de Diego-Cabanes C; Gómez-Bertomeu F; Basora-Gallisà J
Rev Esp Salud Publica; 2020 Jun; 94():. PubMed ID: 32588837
[TBL] [Abstract][Full Text] [Related]
2. Influence of prior comorbidities and chronic medications use on the risk of COVID-19 in adults: a population-based cohort study in Tarragona, Spain.
Vila-Córcoles A; Ochoa-Gondar O; Satué-Gracia EM; Torrente-Fraga C; Gomez-Bertomeu F; Vila-Rovira A; Hospital-Guardiola I; de Diego-Cabanes C; Bejarano-Romero F; Basora-Gallisà J
BMJ Open; 2020 Dec; 10(12):e041577. PubMed ID: 33303459
[TBL] [Abstract][Full Text] [Related]
3. Susceptibility and risk of SARS-COV-2 infection among middle-aged and older adults in Tarragona area, Spain.
Satué-Gracia EM; Vila-Córcoles A; de Diego-Cabanes C; Vila-Rovira A; Torrente-Fraga C; Gómez-Bertomeu F; Hospital-Guardiola I; Ochoa-Gondar O; Martín-Luján F
Med Clin (Barc); 2022 Mar; 158(6):251-259. PubMed ID: 34074472
[TBL] [Abstract][Full Text] [Related]
4. COVID19-related and all-cause mortality risk among middle-aged and older adults across the first epidemic wave of SARS-COV-2 infection: a population-based cohort stuJune 2020.dy in Southern Catalonia, Spain, March-.
Vila-Corcoles A; Satue-Gracia E; Vila-Rovira A; de Diego-Cabanes C; Forcadell-Peris MJ; Hospital-Guardiola I; Ochoa-Gondar O; Basora-Gallisa J
BMC Public Health; 2021 Oct; 21(1):1795. PubMed ID: 34615512
[TBL] [Abstract][Full Text] [Related]
5. Susceptibility and risk of SARS-COV-2 infection among middle-aged and older adults in Tarragona area, Spain.
Satué-Gracia EM; Vila-Córcoles A; de Diego-Cabanes C; Vila-Rovira A; Torrente-Fraga C; Gómez-Bertomeu F; Hospital-Guardiola I; Ochoa-Gondar O; Martín-Luján F
Med Clin (Engl Ed); 2022 Mar; 158(6):251-259. PubMed ID: 35492428
[TBL] [Abstract][Full Text] [Related]
6. Use of distinct anti-hypertensive drugs and risk for COVID-19 among hypertensive people: A population-based cohort study in Southern Catalonia, Spain.
Vila-Corcoles A; Satue-Gracia E; Ochoa-Gondar O; Torrente-Fraga C; Gomez-Bertomeu F; Vila-Rovira A; Hospital-Guardiola I; de Diego-Cabanes C; Bejarano-Romero F; Rovira-Veciana D; Basora-Gallisa J
J Clin Hypertens (Greenwich); 2020 Aug; 22(8):1379-1388. PubMed ID: 32710674
[TBL] [Abstract][Full Text] [Related]
7. Determinants of COVID-19 disease severity in patients with underlying rheumatic disease.
Santos CS; Morales CM; Álvarez ED; Castro CÁ; Robles AL; Sandoval TP
Clin Rheumatol; 2020 Sep; 39(9):2789-2796. PubMed ID: 32720259
[TBL] [Abstract][Full Text] [Related]
8. Rapid Epidemiological Analysis of Comorbidities and Treatments as risk factors for COVID-19 in Scotland (REACT-SCOT): A population-based case-control study.
McKeigue PM; Weir A; Bishop J; McGurnaghan SJ; Kennedy S; McAllister D; Robertson C; Wood R; Lone N; Murray J; Caparrotta TM; Smith-Palmer A; Goldberg D; McMenamin J; Ramsay C; Hutchinson S; Colhoun HM;
PLoS Med; 2020 Oct; 17(10):e1003374. PubMed ID: 33079969
[TBL] [Abstract][Full Text] [Related]
9. CPAP management of COVID-19 respiratory failure: a first quantitative analysis from an inpatient service evaluation.
Ashish A; Unsworth A; Martindale J; Sundar R; Kavuri K; Sedda L; Farrier M
BMJ Open Respir Res; 2020 Nov; 7(1):. PubMed ID: 33148777
[TBL] [Abstract][Full Text] [Related]
10. New-onset atrial fibrillation: incidence, characteristics, and related events following a national COVID-19 lockdown of 5.6 million people.
Holt A; Gislason GH; Schou M; Zareini B; Biering-Sørensen T; Phelps M; Kragholm K; Andersson C; Fosbøl EL; Hansen ML; Gerds TA; Køber L; Torp-Pedersen C; Lamberts M
Eur Heart J; 2020 Jun; 41(32):3072-3079. PubMed ID: 32578859
[TBL] [Abstract][Full Text] [Related]
11. IMPACT OF COMORBIDITIES IN MEXICAN SARS-COV-2-POSITIVE PATIENTS: A RETROSPECTIVE ANALYSIS IN A NATIONAL COHORT.
Kammar-García A; Vidal-Mayo JJ; Vera-Zertuche JM; Lazcano-Hernández M; Vera-López O; Segura-Badilla O; Aguilar-Alonso P; Navarro-Cruz AR
Rev Invest Clin; 2020; 72(3):151-158. PubMed ID: 32584330
[TBL] [Abstract][Full Text] [Related]
12. Description of COVID-19 in HIV-infected individuals: a single-centre, prospective cohort.
Vizcarra P; Pérez-Elías MJ; Quereda C; Moreno A; Vivancos MJ; Dronda F; Casado JL;
Lancet HIV; 2020 Aug; 7(8):e554-e564. PubMed ID: 32473657
[TBL] [Abstract][Full Text] [Related]
13. Incidence and risk conditions of ischemic stroke in older adults.
Satue E; Vila-Corcoles A; Ochoa-Gondar O; de Diego C; Forcadell MJ; Rodriguez-Blanco T; Barnes L; Jariod M
Acta Neurol Scand; 2016 Oct; 134(4):250-7. PubMed ID: 26592375
[TBL] [Abstract][Full Text] [Related]
14. Acute Kidney Injury in COVID-19 Patients: An Inner City Hospital Experience and Policy Implications.
Zahid U; Ramachandran P; Spitalewitz S; Alasadi L; Chakraborti A; Azhar M; Mikhalina G; Sherazi A; Narh JT; Khattar P; Bedi P
Am J Nephrol; 2020; 51(10):786-796. PubMed ID: 33011717
[TBL] [Abstract][Full Text] [Related]
15. Asymptomatic SARS-CoV-2 Infection in Nursing Homes, Barcelona, Spain, April 2020.
Borras-Bermejo B; Martínez-Gómez X; San Miguel MG; Esperalba J; Antón A; Martin E; Selvi M; Abadías MJ; Román A; Pumarola T; Campins M; Almirante B
Emerg Infect Dis; 2020 Sep; 26(9):2281-3. PubMed ID: 32574139
[TBL] [Abstract][Full Text] [Related]
16. Risk factors for SARS-CoV-2 among patients in the Oxford Royal College of General Practitioners Research and Surveillance Centre primary care network: a cross-sectional study.
de Lusignan S; Dorward J; Correa A; Jones N; Akinyemi O; Amirthalingam G; Andrews N; Byford R; Dabrera G; Elliot A; Ellis J; Ferreira F; Lopez Bernal J; Okusi C; Ramsay M; Sherlock J; Smith G; Williams J; Howsam G; Zambon M; Joy M; Hobbs FDR
Lancet Infect Dis; 2020 Sep; 20(9):1034-1042. PubMed ID: 32422204
[TBL] [Abstract][Full Text] [Related]
17. Characteristics and outcomes of a cohort of COVID-19 patients in the Province of Reggio Emilia, Italy.
Giorgi Rossi P; Marino M; Formisano D; Venturelli F; Vicentini M; Grilli R;
PLoS One; 2020; 15(8):e0238281. PubMed ID: 32853230
[TBL] [Abstract][Full Text] [Related]
18. Characteristics and outcome of lung cancer patients and Covid-19 infection in a second-level hospital during the first 3 months of the pandemic.
Rogado J; Serrano-Montero G; Pangua C
Med Clin (Barc); 2020 Nov; 155(9):411-413. PubMed ID: 32883512
[No Abstract] [Full Text] [Related]
19. Comorbidities and Mortality in Patients With COVID-19 Aged 60 Years and Older in a University Hospital in Spain.
Posso M; Comas M; Román M; Domingo L; Louro J; González C; Sala M; Anglès A; Cirera I; Cots F; Frías VM; Gea J; Güerri-Fernández R; Masclans JR; Noguès X; Vázquez O; Villar-García J; Horcajada JP; Pascual J; Castells X
Arch Bronconeumol (Engl Ed); 2020 Nov; 56(11):756-758. PubMed ID: 32782092
[No Abstract] [Full Text] [Related]
20. Efficacy of hydroxychloroquine for post-exposure prophylaxis to prevent severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection among adults exposed to coronavirus disease (COVID-19): a structured summary of a study protocol for a randomised controlled trial.
Barnabas RV; Brown E; Bershteyn A; Miller RS; Wener M; Celum C; Wald A; Chu H; Wesche D; Baeten JM;
Trials; 2020 Jun; 21(1):475. PubMed ID: 32493478
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
